Working groups

Objectives

This WG is aimed at producing guides, publications and ICT-based tools to prevent high BP in children and adolescents taking into account different confounding factors (obesity, physical activity, eating patterns, smoking, social and psychological factors, family communication skills) for a wide range of target groups (clinicians, researchers, decision-makers, patient organisations, families, media and general society representing organisations).

Furthermore, within this WP the economic impact of recommended policies and stakeholders’ intervention will be assessed.

Specific Tasks

T4.1.

Develop and propose actions in professional daily environments to prevent BP elevation mainly addressed to health care professionals and decision makers.

T4.2.

Generate policy action recommendations to provide a better response to this problem assessing the economy impact of each proposed measure (efficiency and effectiveness in childhood interventions and the corresponding health impact and cost reduction in future adulthood)

T4.3.

Elaborate and propose prevention actions and recommendations for the parents, patients and educators.

T4.4.

Review good and best practices regarding high BP prevention strategies employing e-Health and m-Health services for the developmental age.

T4.5.

Design a MOOC e-learning module for both clinicians and main stakeholders (industry, parents, educators, children & adolescents and policy makers) on the most effective measures to prevent high BP among children and adolescents.

T4.6.

Create the HyperChildNET Ecosystem of Stakeholders both locally and transnationally and undergo co-creation activities with real representatives of each category in order to understand their specific needs, preferences and behaviours on which later developing suitable prevention strategies and related tools (focus groups / brainstorming sessions / interviews / role playing / shadowing).

T4.7.

To perform an economic evaluation of the recommended policies and stakeholders’ intervention with societal perspective and long-term time horizon based on the modelling of the natural history of the disease and the expected effectiveness of the recommended policies for measuring, prevent and control high BP in children and adolescents.

Key results

D4.1.

White paper on high BP prevention in children and adolescents (including guidelines, protocols and policy proposals).

D4.2.

Guide with specific recommendations for the target groups, parents and educators on how to reduce BP values in children and adolescents.

D4.3.

Web-based platform with a repository of best practices on e-Health, especially m-Health, for the prevention of high BP in children and adolescents.

D4.4.

Open and free training module (MOOC based training action) for clinicians and main stakeholders to guarantee awareness of effective prevention measures.

D4.5.

Report on the economic evaluation (cost-effectiveness) of the proposed clinical and population based public health interventions for BP prevention.

For more information, you can contact

D_Drozdz WG4 leader PREVENTION

Prof Dorota Drozdz

WG4 Leader.
PREVENTION of high BP in children and adolescents

Prof. Drozdz leads the Pediatric Nephrology and Hypertension Department at University Medical College in Krakow. She has over 25 years of expertise in clinical and experimental research on pediatric kidney diseases and hypertension.

Prof-Claudio-Borghi-(WG4-Vice-Leader)

Prof Claudio Borghi

WG4 Vice Leader.
PREVENTION of high BP in children and adolescents

Claudio Borghi is the Chief of the Department of Medicine of the University of Bologna and Head of the Hypertension Unit Center for the Atherosclerosis and the Heart Failure Clinic. He is particularly focused on the pharmacological and therapeutic aspects of hypertension.

WG members

Vesna Herceg-Cavrak

Croatia

Children’s Hospital Zagreb

Inna Kramer

Estonia

Tallinn Children’s Hospital Foundation

Lagle Suurorg

Estonia

Tallinn Children’s Hospital Foundation

Claudio Borghi

Italy

University of Bologna

Elettra Oleari

Italy

Ospedale San Raffaele

Dorota Drozdz

Poland

Jagiellonian University Medical College

Javier Morales

Spain

Alter Farmacia SA

Beatriz G Lopez-Valcarcel

Spain

University of Las Palmas de Gran Canaria

Rosita Gabbianelli

Italy

University of Camerino

Małgorzata Wójcik

Poland

University Children’s Hospital of Cracow

Saša Missoni

Croatia

Institute for Anthropological Research

Dragan Radovanovic

Serbia

University of Nis. Faculty of Sport and Physical Education

Julio Álvarez

Spain

University of Valencia

Anette Melke

Germany

Hannover Medical School

Related posts